The Transcatheter Cardiovascular Therapeutics (TCT) meeting is the world’s largest educational meeting specializing in interventional cardiovascular medicine. This year, it will take place on September 25-29, 2019 in San Francisco, California.

GCMI and T3 Labs will be attending as an exhibitor at TCT again this year, and our booth number is A2118. We’re excited to spend this time discussing the most recent developments in the cardiovascular field, as well as our experience in delivering high-value preclinical testing and training for cardiothoracic devices. 

“At T3 Labs they have the perfect setup for what we needed. From the cath lab to fluoroscopy to large animal proficiency, not to mention years of expertise specific to cardiology.” – Dr. Rebecca Levit, Chief Scientific Officer of CorAmi Therapeutics. Read more. 

Follow GCMI/T3 Labs on LinkedIn and Twitter

T3 Labs is an industry-leading preclinical CRO that performs transcatheter cardiovascular device testing and training, amongst many other therapeutic areas. T3 Labs’ GLP preclinical program for transcatheter interventional cardiovascular devices includes experience in models of ischemia, transcatheter/interventional implants, telemetry, vascular access etc. Our preclinical CRO employs the most appropriate, efficient model and has all the needed equipment. 

This year, CDRH Office of Cardiovascular Devices (OCVD) staff, in collaboration with the Cardiovascular Research Foundation (CRF), is organizing a one-day FDA University session at the TCT 2019 where FDA staff will provide in-depth regulatory training to the industry. For those participants who already registered for TCT 2019, no additional registration is needed for the FDA University session. If you haven’t registered and would like to attend the FDA session only, please reach out to Dr. Changfu Wu ( for additional information.

Saturday, September 28, 2019, 9:00 AM – 5:00 PM
The Moscone Center, Room 205-206
*The most up to date version of the agenda can be found online:

We look forward to connecting with sponsors, as well as regulatory officials, at TCT 2019 to further understand what they look for in transcatheter innovations and how we can better design preclinical studies for transcatheter devices.

Make sure to find us at TCT 2019 to discuss any transcatheter preclinical medical device testing needs you may have and the guidance that GCMI can provide to take your idea from concept to commercialization. If you would like to schedule an onsite meeting ahead of time, email Deepal Panchal or contact us to set one up!